Research Article
Current Patterns of Management of Advanced Prostate Cancer in Routine Clinical Practice in Spain
Table 1
Patient characteristics and disease status at diagnosis and at data analysis.
| | Characteristics | |
| | Age, years; mean ± SD | 74.8 ± 7.1 | | Comorbidities; (%) | 230 (61.7) | | ECOG performance status, 0-1; (%) | 284 (76.9) | | PSA, ng/mL; mean ± SD | 50.5 ± 135.6 | | Gleason score at diagnosis; (%) | | | 2–6 | 50 (13.8) | | 7 | 140 (38.6) | | 8–10 | 173 (47.7) | | D’Amico risk classification at diagnosis; (%) | | | Low | 23 (6.4) | | Intermediate | 97 (27.2) | | High | 237 (66.4) | | Extent of disease; (%) | | | Bone metastases | 172 (45.9) | | Lymph node | 89 (23.7) | | Lung metastases | 22 (5.9) | | Pain associated with disseminated disease; (%) | 227 (60.6) |
|
|
Missing data on variable: comorbidities, ; ECOG, ; Gleason score, ; D’Amico risk group classification, . SD: standard deviation; PCa: prostate cancer; ECOG: Eastern Cooperative Oncology Group; PSA: prostate specific antigen.
|
